Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma

BACKGROUND: Frequent disease relapse and a lack of effective therapies result in a very poor outcome in pancreatic ductal adenocarcinoma (PDAC) patients. Thus, identification of prognostic biomarkers and possible therapeutic targets is essential. Besides their function in cell–cell adhesion, desmogl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Ormanns, Steffen, Altendorf-Hofmann, Annelore, Jackstadt, Rene, Horst, David, Assmann, Gerald, Zhao, Yue, Bruns, Christiane, Kirchner, Thomas, Knösel, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4815888/
https://ncbi.nlm.nih.gov/pubmed/26469831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados